What VALEANT PHARMACEUTICALS INTERNATIONAL's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ubben Jeffrey W | Director | May 26 | Withheld — tax / exercise cost · F | −124 | $224.63 | −$27.9K | 3,117 |
| Ubben Jeffrey W | Director | May 22 | Grant / award · A | +1,607 | — | — | 3,241 |
| Provencio Norma Ann | Director | Sep 28 | Disposition to Issuer · D | −39,574 | — | — | 0 |
| ValueAct Holdings, L.p. | 10% owner | Sep 28 | Disposition to Issuer · D | −15,138,358 | — | — | 0 |
| ValueAct Holdings, L.p. | 10% owner | Sep 28 | Disposition to Issuer · D | −24,687 | — | — | 0 |
| Chaudhuri Bhaskar | President | Sep 28 | Disposition to Issuer · D | −333,438 | — | — | 0 |
| Karlson Elisa A. | EVP, Chief Admin Officer | Sep 28 | Disposition to Issuer · D | −218,663 | — | — | 0 |
| Pearson J. Michael | CEO and Chairman | Sep 28 | Disposition to Issuer · D | −1,931,505 | — | — | 0 |
| Min Steve T. | EVP, General Counsel | Sep 28 | Disposition to Issuer · D | −213,069 | — | — | 0 |
| Blott Peter J | EVP, Chief Financial Officer | Sep 28 | Disposition to Issuer · D | −216,889 | — | — | 0 |
| De Silva Rajiv | Chief Operating Officer | Sep 28 | Disposition to Issuer · D | −261,994 | — | — | 0 |
| Stefano Stephen F. | Director | Sep 28 | Disposition to Issuer · D | −10,902 | — | — | 0 |
| Lonner Anders | Director | Sep 28 | Disposition to Issuer · D | −12,766 | — | — | 0 |
| Melas Kyriazi Theo | Director | Sep 28 | Disposition to Issuer · D | −60,627 | — | — | 0 |
| Ingram Robert A | Director | Sep 28 | Disposition to Issuer · D | −79,053 | — | — | 0 |
| Koppes Richard | Director | Sep 28 | Disposition to Issuer · D | −54,523 | — | — | 0 |
| Kugelman Larry | Director | Sep 28 | Disposition to Issuer · D | −55,589 | — | — | 0 |
| Morfit G Mason | Director | Sep 28 | Disposition to Issuer · D | −24,687 | — | — | 0 |
| De Silva Rajiv | Chief Operating Officer | Aug 24 | Withheld — tax / exercise cost · F | −1,343 | $57.02 | −$76.6K | 94,101 |
| De Silva Rajiv | Chief Operating Officer | Aug 24 | Withheld — tax / exercise cost · F | −1,044 | $57.02 | −$59.5K | 95,444 |
Loading...